Insurance News & Info

ZURICH (Reuters) – Swiss drugmaker Novartis said on Thursday it would investigate alleged drug approval irregularities in India after a parliamentary report found the country's regulator colluded with pharmaceutical firms to speed up approval … View full post on Yahoo! Health News

WASHINGTON (Reuters) – U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections. The Food and Drug Administration staff… View full post on Yahoo! Health News

ZURICH (Reuters) – Swiss drugmaker Roche has ended efforts to develop a heart disease drug that according to some industry analysts could have achieved $10 billion annual sales, after poor results from a late stage trial. The Data and Safety Monit… View full post on Yahoo! Health News

German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer. View full post on Yahoo! Health News

WASHINGTON (Reuters) – Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deemed to outweigh i… View full post on Yahoo! Health News

WASHINGTON (Reuters) – U.S. drug reviewers said Regeneron Pharmaceuticals Inc's drug to prevent gout flares worked, but questioned its side effects and whether it did enough to help patients. The Food and Drug Administration staff said the dru… View full post on Yahoo! Health News

(Reuters) – Indian drugmaker Dr Reddy's Laboratories has received U.S. Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday. The tablets a… View full post on Yahoo! Health News

(Reuters) – Aveo Pharmaceuticals Inc said a combination of its experimental drug to treat a type of lung cancer and the standard of care did not significantly improve the response and survival rate in a mid-stage study. A combination of Aveo's… View full post on Yahoo! Health News

(Reuters) – Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and neurological conditions, and willing to spend $4 billion o… View full post on Yahoo! Health News

(Reuters) – Salix Pharmaceuticals Ltd said U.S. health regulators have extended the review date by three months for its experimental pill for HIV therapy-related diarrhea. The U.S. Food and Drug Administration was to review the drug, crofelemer, o… View full post on Yahoo! Health News